Stocklytics Platform
Asset logo for symbol MLTX
MoonLake Immunotherapeutics
MLTX53
$52.16arrow_drop_up0.75%$0.39
Asset logo for symbol MLTX
MLTX53

$52.16

arrow_drop_up0.75%

Income Statement (MLTX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
EBIT-$43.11M-$30.57M-$19.82M-$15.02M-$12.97M
EBITDA-$43.07M-$30.55M-$19.79M-$15.02M-$12.97M
gross Profit--$28.11K-$22.81K$16.44K-$3,290.00
NET Income-$35.39M-$24.26M-$13.67M-$7.43M-$9.42M
total Revenue$0.00$0.00$19.73K$19.73K$0.00

Balance Sheet (MLTX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
cash Equivalents-----
net Debt-$371.96M-$339.44M-$454.77M-$447.47M-$317.99M
stockholders Equity$488.19M$520.66M$542.55M$495.67M$424.93M
total Assets$518.21M$544.87M$564.11M$526.54M$500.21M
total Debt$3.68M$3.34M$3.66M$3.69M$169.42K
total Liabilities$22.71M$14.84M$11.73M$13.04M$10.57M

Cash Flow (MLTX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
financing Cash Flow$183.09K$0.00$50.97M$28.41M$0.00
free Cash Flow-$25.40M-$27.89M-$15.16M-$12.62M-$9.25M
investing Cash Flow-----
operating Cash Flow-$25.27M-$27.89M-$14.94M-$12.34M-$9.25M

MoonLake Immunotherapeutics (MLTX) Financials

The income statement for MoonLake Immunotherapeutics (MLTX) provides a snapshot of the company's financial performance over a specific period. It shows the revenue generated by the company, as well as the costs and expenses incurred in generating that revenue. The income statement also includes important financial metrics such as gross profit, EBIT (earnings before interest and taxes), EBITDA (earnings before interest, taxes, depreciation, and amortization), and net income from stockholders.
Gross profit is the revenue remaining after deducting the cost of goods sold, and it represents the core profitability of the company. EBIT is a measure of operating profitability and shows how much profit a company generates from its core activities before taking into account interest and taxes. EBITDA is similar to EBIT, but it adds back depreciation and amortization expenses to get a clearer picture of a company's operating performance.
Net income from stockholders is the profit left over after all expenses and taxes have been deducted and is the ultimate measure of a company's profitability. This figure reflects the amount of money that is available to be distributed to shareholders or reinvested in the business. Total revenue represents the total amount of money earned by the company from its operations, including both sales of goods and services.
The balance sheet is a financial statement that provides a snapshot of a company's financial condition at a specific point in time. It shows the company's assets, liabilities, and stockholders' equity. Assets represent the company's resources, such as cash, inventory, and property. Liabilities are the company's debts and obligations, such as loans and accounts payable. Stockholders' equity represents the company's net worth, which is the residual interest in the assets after deducting liabilities.
Cash equivalents are highly liquid assets that can be used to meet short-term obligations. They include cash on hand, as well as highly liquid investments such as Treasury bills and money market funds. Net debt is the difference between a company's total debt and its cash and cash equivalents. It is a measure of a company's financial leverage and its ability to meet its debt obligations. Stockholders' equity is the residual interest in the assets of a company after deducting liabilities and represents the ownership interest of the shareholders.
Total assets represent the sum of a company's assets, including both current and non-current assets. They provide a picture of the company's overall financial health and its ability to generate future cash flows. Total debt represents the sum of a company's short-term and long-term debt obligations. It includes both current liabilities, such as accounts payable, and long-term debt, such as bonds or mortgages.
Total liabilities represent the sum of a company's debts and obligations, including both current and long-term liabilities. They provide a measure of a company's financial risk and its ability to meet its financial obligations. Cash flow is the movement of cash into or out of a company. It shows how a company sources and uses its cash, including operating activities, investing activities, and financing activities.
Financing cash flow represents the cash flow generated from activities such as issuing and repurchasing shares, issuing or repaying debt, and paying dividends. It shows how a company raises capital and distributes it to its shareholders. Free cash flow is a measure of a company's cash flow generation after accounting for all cash outflows required to maintain or expand its asset base. Investing cash flow represents the cash flow generated from activities such as buying or selling long-term assets or making investments in other companies.
Operating cash flow represents the cash flow generated by a company's core operations. It reflects the company's ability to generate cash from its day-to-day business activities. These cash flows are used to fund the company's working capital needs and cover its operating expenses.
add MoonLake Immunotherapeutics to watchlist

Keep an eye on MoonLake Immunotherapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level